Bank Julius Baer & Co. Ltd, Zurich Regenxbio Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	BUY	$17.23 - $21.71 $146,506 - $184,600	8,503 New	8,503 $170,000
Q1 2023 May 11, 2023	SELL	$18.08 - $24.55 $26,722 - $36,284	-1,478 Reduced 14.04%	9,046 $171,000
Q4 2022 Jan 24, 2023	SELL	$20.4 - $24.73 $53,713 - $65,114	-2,633 Reduced 20.01%	10,524 $239,000
Q3 2022 Nov 04, 2022	BUY	$22.29 - $35.04 $39,876 - $62,686	1,789 Added 15.74%	13,157 $348,000
Q2 2022 Jul 22, 2022	SELL	$19.35 - $35.04 $85,488 - $154,806	-4,418 Reduced 27.99%	11,368 $281,000
Q1 2022 May 09, 2022	SELL	$24.62 - $34.31 $14,821 - $20,654	-602 Reduced 3.67%	15,786 $524,000
Q4 2021 Feb 15, 2022	BUY	$30.19 - $40.28 $294,835 - $393,374	9,766 Added 147.48%	16,388 $536,000
Q3 2021 Nov 12, 2021	SELL	$29.09 - $45.68 $22,253 - $34,945	-765 Reduced 10.36%	6,622 $278,000
Q2 2021 Jul 23, 2021	SELL	$32.46 - $40.48 $60,992 - $76,061	-1,879 Reduced 20.28%	7,387 $287,000
Q1 2021 May 10, 2021	SELL	$33.61 - $49.95 $333,209 - $495,204	-9,914 Reduced 51.69%	9,266 $316,000
Q4 2020 Feb 24, 2021	SELL	$26.52 - $49.35 $50,388 - $93,765	-1,900 Reduced 9.01%	19,180 $870,000
Q4 2020 Feb 12, 2021	BUY	$26.52 - $49.35 $245,840 - $457,474	9,270 Added 78.49%	21,080 $870,000
Q3 2020 Nov 10, 2020	BUY	$27.01 - $40.26 $282,902 - $421,683	10,474 Added 783.98%	11,810 $278,000
Q2 2020 Aug 12, 2020	SELL	$27.75 - $43.44 $234,376 - $366,894	-8,446 Reduced 86.34%	1,336 $287,000
Q1 2020 May 13, 2020	BUY	$21.5 - $54.2 $210,313 - $530,184	9,782 New	9,782 $316,000

193

43.5M

58.9K

58.4K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $404M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.